About
Cancer Immunotherapies
Areas of Focus
Categories
Small Molecule PharmaceuticalStem Cell & Cellular TherapySouthwestern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
186
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06362369Lead Sponsor
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
PHASE1/PHASE2Recruiting
126 participants
Started: Aug 23, 2024 · Completed: Dec 31, 2028
NCT04508179Lead Sponsor
A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects
PHASE1Completed
60 participants
Started: Oct 28, 2020 · Completed: Oct 25, 2021
Funding History (1)
D
Jul 17, 2024
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...